APLS Q1 2021 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$3B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$394,000

Operating Income

-$125M

Net Income

-$184M

EPS (Diluted)

$-2.32

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$153M

Free Cash Flow

-$154M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$810M

Total Liabilities

$758M

Stockholders' Equity

$52M

Cash & Equivalents

$265M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$394,000	-$142,000	-177.5%
Operating Income	-$125M	-$99M	-26.1%
Net Income	-$184M	-$169M	-8.8%